Primena upitnika ThyPRO kod bolesnika sa oboljenjem štitaste žlezde u Srbiji
Sažetak
Uvod/Cilj. Upitnik za kvalitet života osoba sa oboljenjem štitaste žlezde The Thyroid Specific Patient Reported Outcome Measure (ThyPRO) je upitnik za samostalno popunjavanje i meri kvaliteta života tih bolesnika. Cilj ovog rada bio je da se ispita validnost i pouzdanost novog prevedenog specifičnog upitnika, ThyPRO kod bolesnika sa bolešću štitaste žlezde u Srbiji. Metode. Proces prevođenja je obavljen uz poštovanje internacionalno prihvaćene metode prevođenja upitnika. Upitnik je validiran na 100 uzastopnih bolesnika sa bolešću štitaste žlezde, koji su bili hospitalizovani od aprila do avgusta 2012. godine u instituciji tercijarnog nivoa zdravstvene zaštite. Interna pouzdanost skala ThyPRO upitnika je ispitana pomoću Cronbach-ovog α koeficijenta. Povezanost godina, pola, nivoa obrazovanja, bračnog statusa, zaposlenosti, mesta življenja, dijagnoze, trenutne terapije, hormonskog statusa i kvaliteta života bolesnika ispitana je korišćenjem Pearson-ovog (r) i Spearman-ovog (ρ) koeficijenta korelacije. Rezultati. Interna konzistencija i pouzdanost skala ThyPRO upitnika je bila zadovoljavajuća. Cronbach-ov α koeficijent je bio veći od 0.83 (0.83–0.95) za 13 skala ThyPRO upitnika. Skorovi su statistički značajno korelirali sa polom bolesnika, zaposlenošću, dijagnozom, sadašnjom terapijom i mestom življenja. Visoko statistički zanačajan inverzni odnos je otkriven između skorova i hormonskog statusa i skorova i dužine trajanja bolesti. Godine starosti, bračni status i nivo tireostimulišućeg hormona nisu uticali na skorove ni jedne skale ovog upitnika. Zaključak. Upitnik ThyPRO se može koristiti u ispitivanju kvaliteta života povezanog sa zdravljem kod bolesnika sa bolešću štitaste žlezde u Srbiji.
Reference
Watt T, Groenvold M, Rasmussen AK, Bonnema SJ, Hegedüs L, Bjorner JB, et al. Quality of life in patients with benign thyroid disorders. A review. Eur J Endocrinol 2006; 154(4): 501−10.
Watt T, Hegedüs L, Rasmussen AK, Groenvold M, Bonnema SJ, Bjorner JB, et al. Which domains of thyroid-related quality of life are most relevant? Patients and clinicians provide com-plementary perspectives. Thyroid 2007; 17(7): 647−54.
Watt T, Rasmussen AK, Groenvold M, Bjorner JB, Watt SH, Bonnema SJ, et al. Improving a newly developed patient-reported outcome for thyroid patients, using cognitive interviewing. Qual Life Res 2008; 17(7): 1009−17.
Watt T, Bjorner JB, Groenvold M, Rasmussen AK, Bonnema SJ, Hegedus L, et al. Establishin construct validity for the thyroid-specific patient reported outcome measure (ThyPRO): an ini-tial examination. Qual Life Res 2009; 18(4): 483−96.
Watt T, Hegedüs L, Groenvold M, Bjorner JB, Rasmussen AK, Bon-nema SJ, et al. Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endo-crinol 2010; 162(1): 161−7.
Marquis P, Keininger D, Acquadro C, de la Loge C. Translating and evaluating questionnaires: cultural issues for international re-search. In: Fayers P, Hays R , editors. Assessing quality of life in clinical trials. Oxford: Oxford University Press; 2005. p. 78−93.
Pekmezovic T, Kisic Tapavcevic D, Kostic J, Drulovic J. Validation and cross-cultural adaptation of the disease-specific questionnaire MSQOL-54 in Serbian multiple sclerosis patients sample. Qual Life Res 2007; 16(8): 1383−7.
Taïeb D, Sebag F, Cherenko M, Baumstarck-Barrau K, Fortanier C, Farman-Ara B, et al. Quality of life changes and clinical out-comes in thyroid cancer patients undergoing radioiodine remnant ablation (RRA) with recombinant human TSH (rhTSH): a randomized controlled study. Clin Endocrinol (Oxf) 2009; 71(1): 115−23.
Chow S, Au K, Choy T, Lee S, Yeung N, Leung A, et al. Health-related quality-of-life study in patients with carcinoma of the thyroid after thyroxine withdrawal for whole body scanning. Laryngoscope 2006; 116(11): 2060−6.
Abraham-Nordling M, Wallin G, Träisk F, Berg G, Calissendorff J, Hallengren B, et al. Thyroid-associated ophthalmopathy; quality of life follow-up of patients randomized to treatment with antithyroid drugs or radioiodine. Eur J Endocrinol 2010; 163(4): 651−7.
Estcourt S, Quinn AG, Vaidya B. Quality of life in thyroid eye disease: impact of quality of care. Eur J Endocrinol 2011; 164(5): 649−55.
Al-Adhami A, Craig W, Krukowski ZH. Quality of life after sur-gery for Graves' disease: comparison of those having surgery intended to preserve thyroid function with those having abla-tive surgery. Thyroid 2012; 22(5): 494−500.
Schmitz-Winnenthal F, Schimmack S, Lawrence B, Maier U, Heidmann M, Buchler MW, et al. Quality of life is not influenced by the extent of surgery in patients with benign goiter. Langenbecks Arch Surg 2011; 396(8): 1157−63.
Shah MD, Witterick IJ, Eski SJ, Pinto R, Freeman JL. Quality of life in patients undergoing thyroid surgery. J Otolaryngol 2006; 35(4): 209−15.
Mishra A, Sabaretnam M, Chand G, Agarwal G, Agarwal A, Verma AK, et al. Quality of life (QoL) in patients with benign thyroid goiters (pre- and post-thyroidectomy): a prospective study. World J Surg 2013; 37(10): 2322−9.
Watt T, Hegedüs L, Bjorner JB, Groenvold M, Bonnema SJ, Rasmussen AK, et al. Is Thyroid Autoimmunity per se a Determinant of Quality of Life in Patients with Autoimmune Hypothy-roidism. Eur Thyroid J 2012; 1(3): 186−92.
Tagay S, Herpertz S, Langkafel M, Erim Y, Freudenberg L, Schöpper N, et al. Health-related quality of life, anxiety and depression in thyroid cancer patients under short-term hypothyroidism and TSH-suppressive levothyroxine treatment. Eur J Endo-crinol 2005; 153(6): 755−63.
Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B. Depression, anxiety, health-related quality of life, and disa-bility in patients with overt and subclinical thyroid dysfunc-tion. Arch Med Res 2006; 37(1): 133−9.
Elberling TV, Rasmussen AK, Feldt-Rasmussen U, Hørding M, Perrild H, Waldemar G.. Impaired health-related quality of life in Graves' disease. A prospective study. Eur J Endocrinol 2004; 151(5): 549−55.
Biondi B, Palmieri EA, Klain M, Schlumberger M, Filetti S, Lombardi G.. Subclinical hyperthyroidism: clinical features and treatment options. Eur J Endocrinol 2005; 152(1): 1−9.
Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Saccà L, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000; 85(12): 4701−5.
Hoftijzer HC, Heemstra KA, Corssmit EP, van der Klaauw AA, Romijn JA, Smit JW. Quality of life in cured patients with dif-ferentiated thyroid carcinoma. J Clin Endocrinol Metab 2008; 93(1): 200−3.
Bell RJ, Rivera-Woll L, Davison SL, Topliss DJ, Donath S, Davis SR. Well-being, health-related quality of life and cardiovascular disease risk profile in women with subclinical thyroid disease - a community-based study. Clin Endocrinol (Oxf) 2007; 66(4): 548−56.
Abraham-Nordling M, Wallin G, Lundell G, Törring O. Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves' disease. Eur J Endocrinol 2007; 156(2): 173−9.
Dagan T, Bedrin L, Horowitz Z, Chaushu G, Wolf M, Kronenberg J, et al. Quality of life of well-differentiated thyroid carcinoma patients. J Laryngo Otol 2004; 118(7): 537−42.
Crevenna R, Zettinig G, Keilani M, Posch M, Schmidinger M, Pirich C, et al. Quality of life in patients with non-metastatic differ-entiated thyroid cancer under thyroxine supplementation therapy. Suppor Care Cancer 2003; 11(9): 597−603.
Tan LG, Nan L, Thumboo J, Sundram F, Tan LK. Health-Related Quality of Life in Thyroid Cancer Survivors. Laryngoscope 2007; 117(3): 507−10.
Miccoli P, Minuto MN, Paggini R, Rucci P, Oppo A, Donatini G, et al. The impact of thyroidectomy on psychiatric symptoms and quality of life. J Endocrinol Invest 2007; 30(10): 853−9.
Dardano A, Bazzzichi L, Bombardieri S, Monzani F. Symptoms in euthyroid Hashimoto's thyroiditis: is there a role for autoim-munity itself. Thyroid 2012; 22(3): 334−5.
Ott J, Promberger R, Kober F, Neuhold N, Tea M, Huber JC, et al. Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: a prospective case-control study in women undergoing thyroidectomy for benign goiter. Thyroid 2011; 21(2): 161−7.
Pelttari H, Sintonen H, Schalin-Jantii C, Valimaki MJ. Health-related quality of life in long-term follow-up of patients with cured TNM Stage I or II differentiates thyroid carcinoma. Clin Endocrinol (Oxf) 2009; 70(3): 493−7.
Tagay S, Herpertz S, Langkafel M, Erim Y, Bockisch A, Senf W, et al. Health-related Quality of Life, depression and anxiety in thyroid cancer patients. Qual Life Res 2006; 15(4): 695−703.